collagenase inhibitors (Syntex)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecollagenase inhibitors (Syntex)
Drug Alias Namemetalloproteinase inhibitors (Syntex)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCollagenase inhibitorsMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinaseCollagenase
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Palo Alto Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Palo Alto Llc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A